通化金马跌2.03%，成交额1.84亿元，主力资金净流出2191.47万元

Core Viewpoint - Tonghua Jinma's stock price has shown a significant increase of 56.56% year-to-date, but has recently experienced a slight decline in the last few trading days [1][2]. Financial Performance - For the first half of 2025, Tonghua Jinma achieved a revenue of 650 million yuan, reflecting a year-on-year growth of 0.12%. The net profit attributable to shareholders was 16.80 million yuan, marking a substantial increase of 34.77% [2]. - The company has cumulatively distributed 210 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of October 16, the stock price was 24.58 yuan per share, with a market capitalization of 23.756 billion yuan. The trading volume was 184 million yuan, with a turnover rate of 0.77% [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on September 11, where it saw a net purchase of 142 million yuan [1]. Shareholder Information - As of June 30, 2025, the number of shareholders increased to 39,500, a rise of 6.54%. The average number of tradable shares per shareholder decreased by 6.13% to 24,457 shares [2]. - Notable shareholders include Innovation Drug and Southern CSI 1000 ETF, with changes in their holdings reported [3].